FDA Inspection
BioLife Plasma Services L.P.BioLife Plasma Services L.P. – FDA Inspection, Mar 20, 2026
Record Details
This FDA Inspection record concerns BioLife Plasma Services L.P., with an inspection on March 20, 2026, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · 1bc9f2db-4865-42c3-9d7f-ad7ebbb66f0e
Inspection Facts
- Inspection number
- 1309358
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 606.100(b)(2)Donor qualifying tests & measurements
- 21 CFR 630.10(a)Donor Eligibility Factors
- 21 CFR 630.30(b)(1)Unsuitable donation - release
- 21 CFR 630.40(a)Notification
- 21 CFR 630.5(b)Improper delegation of activities
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioLife Plasma Services L.P.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 30, 2023 | Not classified | San Francisco District Office |
Other documents for BioLife Plasma Services L.P.
- FDA Inspection 1202680 - 2023-03-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.